 | ||||||||||||
|
News
Thrombophlebitis
| A Word from Dr. Pfenninger Preventing blood clots while traveling| A Word from Dr. Pfenninger Preventing blood clots while traveling| By the Midland Daily News Midland Daily News Posted: Monday, May 13, 2013 11:00 am. Deep vein thrombophlebitis (DVT, blood clots) of the legs increases with longer airplane flights. Midland Daily News - Mon, 13 May 2013 08:06 | |
 | Why Do Varicose Veins Occur During Pregnancy? Some patients can develop prominent veins on the vulva, and even more serious conditions such as painful superficial thrombophlebitis and Deep Vein Thrombosis (DVT) can occur. Usually, the issues worsen in the later phase of pregnancy. Once the ... Hive Health Media (blog) - Sun, 19 May 2013 10:55 |
| The Equine Heart: Power Plant Unequaled The only common condition affecting the veins of horses is thrombophlebitis of the jugular vein(s) caused by repeated jugular vein puncture, injection of material outside the vein, or use of a jugular vein catheter. The resulting chemical or physical ... TheHorse.com - Mon, 29 Apr 2013 09:19 | |
| Nashville Predators hope Pekka Rinne shakes team's injury hex in goal All went well until 2006 when Vokoun, after complaining of back pain, was diagnosed with pelvic thrombophlebitis — blood clots in his abdomen. The condition surfaced as Vokoun was establishing himself as one of the NHL's top goalies. It knocked him ... The Tennessean - Mon, 13 May 2013 00:13 | |
| Alnylam Presents Key Pre-Clinical Proof-of-Concept Data for ALN-AS1, an RNAi ... Treatment options for AIP patients suffering from an acute attack are limited; patients are treated with intravenous heme analogues that have a slow onset and can result in severe thrombophlebitis and iron overload. Currently there is no approved ... Fort Mills Times - Fri, 17 May 2013 05:24 | |
| Durata Announces Data from Phase I Trial of Dalbavancin The most common treatment emergent AE reported was mild pain in the extremity, reported by 2 subjects, without evidence of thrombophlebitis. No subject withdrew or was discontinued from the study. No laboratory abnormality was attributed to Dalbavancin. Benzinga - Mon, 29 Apr 2013 04:38 | |
1